Vaccinex grants stock options and 7% salary increases to top executives

VACCINEX, INC.

CEO Maurice Zauderer receives options for 28,000 shares at $1.29, vesting over 4 years.
CSO Ernest Smith gets options for 20,000 shares; CFO Scott Royer gets 16,000 shares at same price.
Base salaries raised 7%: Zauderer to $406,600, Smith to $287,981, Royer to $262,223.
Options granted under 2018 Omnibus Incentive Plan, expire 10 years from grant date April 1, 2022.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.